AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/15/2024 | Press release | Distributed by Public on 05/15/2024 05:48
Please select the service you want to use:
Smartlinks | Xi'an Jiaotong University | News | Education | University | Universities and Colleges
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact